Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killing

Clinical and Experimental Pharmacology & Physiology
W R Wilson, F B Pruijn

Abstract

1. Hypoxia arises in solid tumour because of inefficient blood supply. While hypoxic cells are resistant to radiotherapy and probably to many chemotherapeutic drugs they can, in principle, be turned to advantage through the development of hypoxia-activated cytotoxic drugs (bioreductive drugs). 2. Three general approaches to exploiting tumour hypoxia are discussed. The first relies on fluctuating blood flow in tumours and the consequent cycling of cells through the hypoxic compartment. The second incorporates a prodrug approach in which drug activation gives rise to cytotoxic metabolites which diffuse out of hypoxic zones. The third utilizes selective inhibitors of tumour blood flow to induce additional hypoxia and thus enhance bioreductive drug activation. 3. The latter two approaches are illustrated by recent studies with the dinitrobenzamide nitrogen mustard class of bioreductive drugs and their combination with the tumour blood flow inhibitor 5,6-dimethylxanthenone-4-acetic acid.

References

May 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J W Denham
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·W R WilsonW A Denny
Jul 1, 1991·International Journal of Radiation Biology·H S EdwardsI J Stratford
Jan 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Denekamp, S Hill
Apr 19, 1989·Journal of the National Cancer Institute·D J Chaplin
Jul 1, 1986·International Journal of Radiation Oncology, Biology, Physics·R P Hill
May 1, 1988·International Journal of Radiation Oncology, Biology, Physics·R A GatenbyG J Broder
Jan 1, 1994·International Journal of Radiation Biology·J M Brown, A J Giaccia
Jan 1, 1994·Clinical Oncology : a Journal of the Royal College of Radiologists·C P Lowdell
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·G E Adams, I J Stratford
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·B G SiimW R Wilson
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·W A DennyS M Pullen
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·W R WilsonD C Ware
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·S CliffeW R Wilson
Jun 1, 1993·Cancer Metastasis Reviews·P Workman, I J Stratford
Jan 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M HöckelP Vaupel

❮ Previous
Next ❯

Citations

Oct 8, 1999·Pharmacology & Therapeutics·G M Dubowchik, M A Walker
May 1, 1997·Lancet·A L Harris
Jul 5, 2005·Expert Opinion on Investigational Drugs·R M Phillips
Oct 18, 2002·Expert Review of Anticancer Therapy·Bruce C Baguley, William R Wilson
Feb 25, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer HaynesCatherine A O'Brien

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.